Drugs / Non-convalescent Plasma
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04359810 Comparator | Apr → Dec 2020 | COVID-19 | Max O'Donnell | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Non-convalescent Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04359810 ↗ |
| Known as | control plasma | “Non-convalescent Plasma (control plasma)” NCT04359810 ↗ |
| Route | Other | “receive a single transfusion of either convalescent plasma or normal control plasma” PMID 33974559 ↗ Jul 2021 |